Show simple item record

Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells

dc.contributor.authorLanza,en_US
dc.contributor.authorCastoldi,en_US
dc.contributor.authorCastagnar,en_US
dc.contributor.authorTodd,en_US
dc.contributor.authorMoretti,en_US
dc.contributor.authorSpisani,en_US
dc.contributor.authorLatorraca,en_US
dc.contributor.authorFocarile,en_US
dc.contributor.authorRoberti,en_US
dc.contributor.authorTraniello,en_US
dc.date.accessioned2010-06-01T21:40:01Z
dc.date.available2010-06-01T21:40:01Z
dc.date.issued1998-10en_US
dc.identifier.citationLanza, ; Castoldi, ; Castagnar, ; Todd, ; Moretti, ; Spisani, ; Latorraca, ; Focarile, ; Roberti, ; Traniello, (1998). "Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells." British Journal of Haematology 103(1): 110-123. <http://hdl.handle.net/2027.42/74714>en_US
dc.identifier.issn0007-1048en_US
dc.identifier.issn1365-2141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74714
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9792297&dopt=citationen_US
dc.format.extent1297134 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rights1998 Blackwell Science Ltden_US
dc.subject.otherUPA-Ren_US
dc.subject.otherAcute Myeloid Leukaemiaen_US
dc.subject.otherAML M5 Morphologyen_US
dc.subject.otherTissue Infiltrationen_US
dc.subject.otherChromosome Abnormalitiesen_US
dc.titleExpression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cellsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherDepartment of Biochemistry and Molecular Biology, University of Ferrara, Italyen_US
dc.identifier.pmid9792297en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74714/1/j.1365-2141.1998.00932.x.pdf
dc.identifier.doi10.1046/j.1365-2141.1998.00932.xen_US
dc.identifier.sourceBritish Journal of Haematologyen_US
dc.identifier.citedreferenceBenÈ, M., Castoldi, G.L., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A., van't Veer, M.B., on behalf of the European Group for the Immunological Characterization of Leukemias, EGIL ( 1995 ) Proposals for the immunological classification of acute leukemias. Leukemia, 9, 1783 1786.en_US
dc.identifier.citedreferenceBennett, B., Croll, A.M., Robbie, L.A., Herriot, R. ( 1997 ) Tumour cell u-PA as a cause of fibrinolytic bleeding in metastatic disease. British Journal of Haematology, 99, 570 574.en_US
dc.identifier.citedreferenceBorregaard, N. & Cowland, J. ( 1997 ) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood, 89, 3503 3521.en_US
dc.identifier.citedreferenceBu, G., Warshawsky, I., Schwartz, A.L. ( 1994 ) Cellular receptors for the plasminogen activators. Blood, 83, 3427 3436.en_US
dc.identifier.citedreferenceCao, D., Mizukani, I.F., Garni-Wagner, B.A., Kindzelsky, A.L., Todd, R.F. ( 1995 ) Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release: possible roles of complement receptor type 3 and calcium. Journal of Immunology, 154, 1817 1829.en_US
dc.identifier.citedreferenceCastoldi, G.L. & Cuneo, A. ( 1996 ) Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes. Acute Myelogenous Leukaemia and Myelodysplasia (ed. by B. Lowemberg), pp. 19 32. BailliÈre Tindall, London.en_US
dc.identifier.citedreferenceGadd, S., Majdic, O., Kasinrerk, W., Stockinger, H., Maurer, D., Eher, D., Knapp, W. ( 1990 ) M5, a phosphoinositol linked human myelo-monocytic activation associated antigen. Clinical and Experimental Immunology, 80, 252 256.en_US
dc.identifier.citedreferenceGarni-Wagner, B.A. & Todd, R.F. ( 1995 ) Two epitopes within the ligand binding domain in the human urokinase receptor are defined by select mAb. Leukocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al ), Vol. 1, pp. 945 949. Oxford University Press.en_US
dc.identifier.citedreferenceGyetko, M.R., Chen, G.H., McDonald, R.A., Goodman, R., Huffnagle, G.B., Willkinson, C.C., Fuller, J.A., Toews, G.B. ( 1996 ) Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. Journal of Clinical Investigation, 97, 1818 1826.en_US
dc.identifier.citedreferenceGyetko, M.R., Sitrin, R.G., Fuller, J., Todd, R.F., III, Petty, H., Standiford, T.J. ( 1995 ) Function of the urokinase receptor (CD87) in neutrophil chemotaxis. Journal of Leukocyte Biology, 58, 533 538.en_US
dc.identifier.citedreferenceGyetko, M.R., Todd, R.F., Wilkinson, C.C., Sitrin, R.G. ( 1994 ) The urokinase receptor is required for human monocyte chemotaxis in vitro. Journal of Clinical Investigation, 93, 1380 1387.en_US
dc.identifier.citedreferenceKindzelskii, A.L., Laska, Z.O., Todd, R.F., Petty, H.R. ( 1996 ) Urokinase-type plasminogen activator receptor recversibly dissociates from complement receptor type III (alpha M beta 2′ CD11b/CD18) during neutrophil polarization. Journal of Immunology, 156, 297 309.en_US
dc.identifier.citedreferenceKnapp, W., Strobl, H., Majdic, O. ( 1994 ) Flow cytometric analysis of cell surface and intracellular antigens in leukemia diagnosis. Cytometry, 18, 187 198.en_US
dc.identifier.citedreferenceLanza, F., Bi, S., Godman, J.M. ( 1993 ) Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia, 7, 1570 1575.en_US
dc.identifier.citedreferenceLanza, F., Campana, D., Knapp, W., Janossy, G., Lacombe, F., Matutes, E., Orfao, A., Schmitz, G. ( 1996 ) Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results?. European Journal of Histochemistry, 40, 7 14.en_US
dc.identifier.citedreferenceLanza, F., Castagnari, B., Rigolin, G.M., Moretti, S., Ferrari, L., Bardi, A., Castoldi, G.L. ( 1997 a) Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells. Leukemia, 11, 1700 1710.en_US
dc.identifier.citedreferenceLanza, F., Latorraca, A., Moretti, S., Castagnari, B., Ferrari, L., Castoldi, G.L. ( 1997 b) Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Cytometry, 30, 134 144.en_US
dc.identifier.citedreferenceLanza, F., Moretti, S., Papa, S., Malavasi, F., Castoldi, G.L. ( 1994 ) Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, 3–7 November, 1993. Haematologica, 79, 374 387.en_US
dc.identifier.citedreferenceLanza, F, Sucai, B., Moretti, S., Castoldi, G.L., Godman, J.M. ( 1995 ) Modulation of cell kinetics and cell cycle status by treating chronic myeloid leukaemia CD34 + cells with p53 antisense phophorothioate oligonucleotides. British Journal of Haematology, 90, 8 14.en_US
dc.identifier.citedreferenceLijnen, H.R. ( 1996 ) Pathophysiology of the plasminogen–plasmin system. International Journal of Clinical and Laboratory Research, 26, 1 6.en_US
dc.identifier.citedreferenceMizukami, I., Vinjamuri, S., Trochelman, D., Todd, R. ( 1990 ) Structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human polymorphonuclear phagocytes. Journal of Immunology, 144, 1841 1848.en_US
dc.identifier.citedreferencePapa, S. & Lanza, F. ( 1996 ) Immunophenotyping Hematological Malignancies. Luigi & Ponzio Editore, Pavia.en_US
dc.identifier.citedreferencePlesner, T., Ploug, M., Ellis, V., Ronne, E., Hoyer-Hansen, G., Wittrup, M., Pedersen, T.L., Tscherning, T., Dano, K., Hansen, N.E. ( 1994 ) The receptor for urokinase type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood, 83, 808 815.en_US
dc.identifier.citedreferencePoncelet, P., George, F., Papa, S., Lanza, F. ( 1996 ) Quantitation of hemopoietic cell antigens in flow cytometry. European Journal of Histochemistry, 40, 15 32.en_US
dc.identifier.citedreferencePyke, C., Kristensen, P., Ralfkiaer, E., Grondahl-Hansen, J., Eriksen, J., Blasi, F., Dano, K. ( 1991 ) Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. American Journal of Pathology, 138, 1059 1065.en_US
dc.identifier.citedreferenceSimon, D., Rao, N., Xu, H., Wei, Y., Majdic, O., Ronne, E., Kobzik, L., Chapman, H. ( 1996 ) Mac-1 (CD11b/ CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood, 88, 3185 3194.en_US
dc.identifier.citedreferenceSitrin, R.G., Todd, R.F., III, Mizukami, I.F., Gross, T.J., Shollenberger, S.B., Gyetko, M.R. ( 1994 ) Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood, 84, 1268 1275.en_US
dc.identifier.citedreferenceSpisani, S., Pareschi, M.C., Buzzi, M., Colamussi, M.L., Biondi, C., Traniello, S., Pagani Zecchini, G., Paglialunga Paradisi, M., Torrini, I., Ferretti, M.E. ( 1996 ) Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Cellular Signaling, 8, 269 277.en_US
dc.identifier.citedreferenceSpisani, S., Traniello, S., Martuccio, T., Rizzuti, O., Cellai, L. ( 1997 ) Ryfamycin inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity. Inflammation, 21, 391 400.en_US
dc.identifier.citedreferenceStephens, R., Tapiovaara, H., Alitalo, R., Reisberg, T., Lymboussakis, A., Myohanen, H., Vaheri, A. ( 1992 ) Cell surface plasminogen activation and leukemia. Fibrinolysis, 6, 35 39.en_US
dc.identifier.citedreferenceTodd, R., III & Petty, H. ( 1997 ) β2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. Journal of Laboratory and Clinical Medicine, 129, 492 498.en_US
dc.identifier.citedreferenceTodd, R.F., Barnathan, E.S., Bohuslav, J., Chapman, A., Cohen, R.L., Felez, J., Howell, J., Johnson, J.G., Knapp, W., Kramer, M., Miles, L.A., Nykjaer, A., Ralkiaer, E., Schuren, E. ( 1995 ) CD87 cluster workshop report. Leukocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al ), Vol. 1, pp. 932 939. Oxford University Press.en_US
dc.identifier.citedreferenceWei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V., Chapman, H.A. ( 1996 ) Regulation of integrin function by the urokinase receptor. Science, 273, 1551 1555.en_US
dc.identifier.citedreferenceXue, W., Kindzelskii, A.L., Todd, R.F., Petti, H.R. ( 1994 ) Physical association of complement receptor type 3 and urokinase type plasminogen activator receptor in neutrophil membranes. Journal of Immunology, 152, 4630 4638.en_US
dc.identifier.citedreferenceYe, R.D. & Boulay, F. ( 1997 ) Structure and function of leukocyte chemoattractant receptors. Advances in Pharmacology, 39, 221 289.en_US
dc.identifier.citedreferenceZigmond, S.H. & Hirsch, J.G. ( 1973 ) Leukocyte locomotion and chemotaxis, new method for evaluation and demonstration of a cell-derived chemotactic factor. Journal of Experimental Medicine, 137, 387 410.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.